Indrayani Biotech’s arm invests in Kniss Laboratories

26 Aug 2023 Evaluate

Indrayani Biotech’s wholly owned subsidiary -- IBL Healthcare has invested in Kniss Laboratories by subscribing to 54,68,934 Equity shares of the Company of face value of Rs 10 each on preferential allotment/private placement basis in two tranches. Thus, Kniss Laboratories becomes subsidiary to the company’s wholly owned subsidiary, IBL Healthcare. Cost of acquisition is Rs 5.47 crore. 

Indrayani Biotech is a company belonging to food sector. They are a part-finance its project to produce cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds. The company also markets and distributes hybrid vegetable seeds manufactured by Hoechst India. It plans to produce these seeds for Hoechst in due course of time.


Indrayani Biotech Share Price

48.00 0.02 (0.04%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Indrayani Biotech 48.00
SIP Industries 6.01
Trescon 15.70
Jayasilpa Floritech
Farmtek Agro Exports
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.